RNA Viruses and Antibody Response

doi:10.3390/books978-3-7258-0109-1

Format

Hardback

License and Copyright

Keywords

SARS-CoV-2; HIV/AIDS; SARS-CoV-2 vaccine; Omicron variant; neutralization titers; third dose vaccine; Chikungunya virus; immunoinformatics; B-cell epitopes; peptides; ELISA; COVID-19; SARS-CoV-2; RBD; immunogenicity; mutant; SARS-CoV-2; COVID-19; cohort study; antibody waning; seroreactivity; electrochemiluminescence assay; fixed-effect models; SARS-CoV-2; nursing home; epidemiology; seroprevalence; pre-vaccination; SARS-CoV-2; nucleocapsid phosphoprotein; monoclonal antibody; immunogenicity; recombinant protein; cross-reactivity; epitopes; mapping antibody repertoires; original antigenic sin; immune imprinting; repeated influenza exposures; broadly neutralizing antibody; influenza A H3N2 virus; SARS-CoV-2; COVID-19; sotrovimab; nirmatrelvir/ritonavir; molnupiravir; remdesivir; human infection; repeated infection; SARS-CoV-2; HIV-1; RSV; neutralizing antibody; neutralization assay; epitope specificity; analysis of serum antibody specificity; monoclonal antibody; SARS-CoV-2; antibody dynamics; vaccine; protection time; mathematical modeling; multiple myeloma; molnupiravir; ritonavir-nirmatrelvir; SARS-CoV-2; belantamab mafodotin; COVID-19; SARS-CoV-2; vaccine; T cell response; neutralizing antibody; breakthrough infection; influenza; vaccine; antibody; virus; COVID-19; convalescent plasma; meta-analysis; randomized controlled trials; mortality; intensive care unit; SARS-CoV-2; COVID-19; antibody response; RNA viruses; SARS-CoV-2; antibody response; infection; vaccination; nucleocapsid protein; spike protein; n/a

Reprint

Download Flyer

RNA Viruses and Antibody Response

Edited by

February 2024

224 pages

ISBN978-3-7258-0110-7 (Hardback)
ISBN978-3-7258-0109-1 (PDF)

https://doi.org/10.3390/books978-3-7258-0109-1

Free Download (PDF)

This is a Reprint of the Special Issue RNA Viruses and Antibody Response that was published in

Biology & Life Sciences

Medicine & Pharmacology

Public Health & Healthcare

Summary

This Special Issue comprises 14 original studies and 2 reviews, and will serve as a platform to further the current knowledge of antibody responses against RNA virus infections.